Literature DB >> 3954933

Intra- and inter-individual variation in pharmacokinetics of intravenously infused amoxycillin and ampicillin to elderly volunteers.

J Sjövall, G Alván, B Huitfeldt.   

Abstract

The purpose of this study was to investigate the disposition of two aminopenicillins and their intra- and inter-individual variation in pharmacokinetic parameters in healthy, elderly volunteers. Two groups, each of 12 active, community-dwelling volunteers between 69 and 83 years of age participated. One group was given 500 mg of amoxycillin, the other group 500 mg of ampicillin as single i.v. infusions. Within the drug groups each volunteer was given the infusion at two different occasions separated by a time-period of 1 week. Amoxycillin and ampicillin were determined in plasma and urine by modern column liquid chromatographic methods. The mean plasma clearance was about 200 ml min-1 1.73 m-2 for both drugs and renal clearance accounted for approximately 80% of this. As expected, drug clearance was correlated to renal function as determined by 51Cr-EDTA. The volume of distribution at steady-state (Vss) was about 0.3 l kg-1 for both drugs. Compared to our previous results in younger subjects, plasma and renal clearances were essentially similar in this study, but slightly longer half-lives and higher Vss were seen for amoxycillin and ampicillin. The intra-individual variation, expressed as the error of a single determination (CV), was small, for plasma clearance 3.7% and 6.4% after amoxycillin and ampicillin. The corresponding inter-individual variation in clearance was higher, 14.4% after amoxycillin, and 11.9% after ampicillin. The results confirm a higher relative efficiency of a crossover vs a completely randomized parallel groups design in parenteral studies of these penicillins. In our elderly subjects there was only an approximately 30% decrease in renal function. This was not enough to reduce the drug clearance and offers an explanation for the similarity between our present results in the elderly and our previous results in younger subjects. Elderly volunteers may be different from patients with disease as a confounding factor. Studies on elderly active and community-dwelling volunteers, as in this study, may therefore be more representative as to the effect of age per se on drug kinetics.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954933      PMCID: PMC1400908          DOI: 10.1111/j.1365-2125.1986.tb05172.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  Analysis of penicillins in biological material by reversed phase liquid chromatography and post-column derivatization.

Authors:  D Westerlund; J Carlqvist; A Theodorsen
Journal:  Acta Pharm Suec       Date:  1979

2.  Problems associated with analysis of pharmacokinetic models.

Authors:  W J Westlake
Journal:  J Pharm Sci       Date:  1971-06       Impact factor: 3.534

3.  Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion.

Authors:  J C Loo; S Riegelman
Journal:  J Pharm Sci       Date:  1970-01       Impact factor: 3.534

4.  Drug trials, the "elderly", and the very aged.

Authors:  C Smith; S Ebrahim; T Arie
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

5.  Multiexponential, multicompartmental, and noncompartmental modeling. II. Data analysis and statistical considerations.

Authors:  E M Landaw; J J DiStefano
Journal:  Am J Physiol       Date:  1984-05

6.  Effect of extracellular water volume on the distribution kinetics of beta-lactam antibiotics as a function of age.

Authors:  A Tsuji; T Terasaki; N Imaeda; K Nishide; E Nakashima
Journal:  J Pharmacobiodyn       Date:  1985-03

7.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

8.  Automated determination of amoxycillin in biological fluids by column switching in ion-pair reversed-phase liquid chromatographic systems with post-column derivatization.

Authors:  J Carlqvist; D Westerlund
Journal:  J Chromatogr       Date:  1985-11-08

9.  Renal excretion of intravenously infused amoxycillin and ampicillin.

Authors:  J Sjövall; D Westerlund; G Alván
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

10.  Dose-dependent absorption of amoxycillin and bacampicillin.

Authors:  J Sjövall; G Alván; D Westerlund
Journal:  Clin Pharmacol Ther       Date:  1985-09       Impact factor: 6.875

View more
  15 in total

1.  Pharmacokinetics of amoxycillin in elderly in-patients.

Authors:  R Janknegt; J Boogaard-Van den Born; B A Hameleers; P M Hooymans; J Rang; C A Smits; M E Willems-Thissen
Journal:  Pharm Weekbl Sci       Date:  1992-02-21

Review 2.  Pharmacokinetic considerations in the eradication of Helicobacter pylori.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

3.  The reproducibility of quinine bioavailability.

Authors:  G Paintaud; G Alván; O Ericsson
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

Review 4.  Genomic architecture of pharmacological efficacy and adverse events.

Authors:  Aparna Chhibber; Deanna L Kroetz; Kelan G Tantisira; Michael McGeachie; Cheng Cheng; Robert Plenge; Eli Stahl; Wolfgang Sadee; Marylyn D Ritchie; Sarah A Pendergrass
Journal:  Pharmacogenomics       Date:  2014-12       Impact factor: 2.533

Review 5.  Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.

Authors:  I D Watson; M J Stewart; D J Platt
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

6.  Scaling beta-lactam antimicrobial pharmacokinetics from early life to old age.

Authors:  Dagan O Lonsdale; Emma H Baker; Karin Kipper; Charlotte Barker; Barbara Philips; Andrew Rhodes; Mike Sharland; Joseph F Standing
Journal:  Br J Clin Pharmacol       Date:  2018-11-26       Impact factor: 4.335

Review 7.  Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.

Authors:  R J Bertz; G R Granneman
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

8.  Nonlinearity of amoxicillin absorption kinetics in human.

Authors:  G Paintaud; G Alván; M L Dahl; A Grahnén; J Sjövall; J O Svensson
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

9.  The influence of labour on the pharmacokinetics of intravenously administered amoxicillin in pregnant women.

Authors:  Anouk E Muller; P Joep Dörr; Johan W Mouton; Joost De Jongh; Paul M Oostvogel; Eric A P Steegers; Rob A Voskuyl; Meindert Danhof
Journal:  Br J Clin Pharmacol       Date:  2008-12       Impact factor: 4.335

Review 10.  Clinical pharmacokinetics of antibacterial drugs in the elderly. Implications for selection and dosage.

Authors:  B R Meyers; P Wilkinson
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.